Ovid Therapeutics Inc. (OVID) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-05-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	8-K	10-K	8-K	10-K	10-K	10-K
Total revenues [+]	1.5	208.4	208.4	12.6	12.6	62.4	0.0	0.0
Royalties			46.9		63.4
Revenue growth	-99.3%	1551.6%	1551.6%	-79.8%
Cost of goods sold	0.0	0.0	84.2	0.0	94.0	0.0	0.0	0.0
Gross profit	1.5	208.4	124.2	12.6	-81.4	62.4	0.0	0.0
Gross margin	100.0%	100.0%	59.6%	100.0%	-645.4%	100.0%
Selling, general and administrative [+]	32.4	37.2	37.2	94.0	30.6	19.3	19.1	15.0
General and administrative	32.4	37.2	37.2		30.6	19.3	19.1	15.0
Research and development	24.6	46.9				42.2	33.8	50.0
Other operating expenses			-37.2		-30.6	62.4
EBITDA [+]	-55.0	124.4		-81.1		-61.2	-52.8	-64.9
EBITDA growth	-144.2%	-253.4%	-252.5%	32.7%		15.8%	-18.7%	188.8%
EBITDA margin	-3662.3%	59.7%	59.6%	-643.0%	-645.4%	-98.1%
Depreciation	0.3	0.1		0.1		0.0	0.0	0.0
EBITA	-55.4	124.4	124.2	-81.2	-81.4	-61.2	-52.8	-65.0
EBITA margin	-3683.6%	59.7%	59.6%	-643.4%	-645.4%	-98.1%
Amortization of intangibles	0.2	0.2		0.2		0.2	0.1	0.1
EBIT [+]	-55.5	124.2	124.2	-81.4	-81.4	-61.4	-52.9	-65.0
EBIT growth	-144.7%	-252.5%	-252.5%	32.6%		16.0%	-18.6%	188.5%
EBIT margin	-3696.4%	59.6%	59.6%	-645.4%	-645.4%	-98.5%
Other income (expense), net	1.4	0.0	0.0	0.4	0.4	0.9	1.0	0.2
Pre-tax income	-54.2	124.2	124.2	-81.0	-81.0	-60.5	-52.0	-64.8
Income taxes	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	1.1%	1.1%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-54.2	122.8	122.8	-81.0	-81.0	-60.5	-52.0	-64.8
Net margin	-3604.7%	58.9%	58.9%	-642.3%	-642.3%	-97.0%

Basic EPS [+]	($0.77)	$1.82	$1.82	($1.39)	($1.39)	($1.54)	($2.11)	($3.35)
Growth	-142.3%	-231.3%	-231.3%	-10.1%		-26.9%	-37.0%	47.1%
Diluted EPS [+]	($0.77)	$1.80	$1.80	($1.39)	($1.39)	($1.54)	($2.11)	($3.35)
Growth	-142.6%	-230.2%	-230.2%	-10.1%		-26.9%	-37.0%	47.1%

Shares outstanding (basic) [+]	70.4	67.5	67.5	58.5	58.5	39.2	24.6	19.3
Growth	4.4%	15.4%	15.4%	49.0%		59.2%	27.3%	96.6%
Shares outstanding (diluted) [+]	70.4	68.1	68.1	58.5	58.5	39.2	24.6	19.3
Growth	3.5%	16.5%	16.5%	49.0%		59.2%	27.3%	96.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.